Arvida Directors Unanimously Support Scheme
Related documents
- NZX Release - Scheme Materials 222kb pdf
- Scheme Booklet 7mb pdf
- Initial Court Orders 5mb pdf
- Proxy & Voting Form 68kb pdf
- Virtual Meeting Guide 4mb pdf
Arvida Directors Unanimously Support Scheme
Key points:
• Scheme Consideration of NZ$1.70 per share is within the Independent Adviser’s assessed valuation range at NZ$1.63 to NZ$1.94 per share
• Arvida Directors unanimously recommend shareholders vote in favour of the Scheme
• Shareholders are strongly encouraged to have their say by voting on the Scheme at a scheme meeting to be held at 2.00pm on 25 September 2024 (NZT) concurrently with the annual meeting
• Shareholders can attend the meeting in person or virtually/online or appoint a proxy of vote in advance
Arvida Group Limited (Arvida) is pleased to confirm that on 25 September 2024 its shareholders will vote at a special meeting on the NZ$1.70 per share cash offer (Scheme Consideration) from Stonepeak Alps BidCo Limited (Stonepeak BidCo) to acquire all of the shares in Arvida.
Arvida has been granted initial orders from the High Court in respect of the scheme of arrangement proposed by Stonepeak BidCo.
The directors of Arvida reiterated their unanimous support for the scheme of arrangement (Scheme) following the release of an Independent Adviser’s Report (IAR) prepared by Grant Samuel. The IAR assessed the Scheme Consideration to be within the Independent Adviser’s valuation range for Arvida shares of NZ$1.63 to NZ$1.94 per share.
Arvida has today released an electronic version of the Scheme Booklet, which includes the formal recommendation by Arvida’s directors, the Notice of Meeting and the full IAR, and a Proxy/Voting Form. These documents are attached to this announcement and also available at www.arvida.co.nz/stonepeak-scheme.
The electronic Scheme Booklet, together with a Proxy/Voting Form, will today be emailed to those shareholders who are registered to receive electronic communications. Hard copies of the Scheme Booklet and the Proxy/Voting Form will be sent to shareholders who have not elected to receive electronic communications.
Arvida Chairman Anthony Beverley said: “The Scheme represents a compelling outcome for Arvida shareholders. The Scheme Consideration of NZ$1.70 per share is a 65% premium to our closing share price on the day prior to the announcement of the Scheme and an 82% premium to the volume-weighted average price of Arvida shares over the 30 days prior to the announcement. The Scheme Consideration is also within the Grant Samuel range. It is the view of Directors that the Scheme Consideration reflects full value for Arvida given the prospects for the business, the economic outlook and the risks facing the business.
“The Scheme provides an opportunity for shareholders to realise certain value for their Arvida shares now for 100% cash consideration without being exposed to the execution risk of implementing Arvida’s strategic plan. We looked at a number of options as part of our value recognition programme that could help close the gap between Arvida’s share price and its intrinsic value, including engaging with other market participants on various capital partnership and merger opportunities, restructuring property and operating options and strategic alternatives for the Company. Through that process it became clear that a full offer for all of Arvida’s shares was superior to the other options the Board considered were realistically available to the Company and would enable Shareholders to realise their investment in cash at a material premium to the share price prior to the announcement.”
Mr Beverley further noted that if the Scheme was not approved and no superior proposal was received, the price at which Arvida shares were likely to trade would be lower than the $1.70 per share offered by Stonepeak BidCo. This point was echoed in Grant Samuel’s report. It advised that if the Scheme did not proceed there may be a reversal of some or all of the share price appreciation that Arvida experienced following the announcement of the Scheme.
Arvida’s shares were trading at $1.03 each immediately prior to the announcement of the Scheme.
Mr Beverley confirmed that Arvida has not received an approach from a party other than Stonepeak to acquire the Company in the period since the Scheme was announced or since the market was informed of an unsolicited acquisition proposal in December 2023. Your Directors consider it unlikely that a superior proposal will emerge at this time.
Conditions and timetable
The Scheme is subject to customary conditions for a transaction of this nature including approval by shareholders at the Scheme Meeting, High Court approval and consent from the Statutory Supervisor of each of Arvida’s retirement villages and under the Overseas Investment Act. The Scheme is also subject to there being no material adverse change event occurring before implementation of the Scheme. Stonepeak BidCo has requested an expedited decision from the Overseas Investment Office, although a decision might not be received ahead of the Scheme Meeting.
The Takeovers Panel has provided its letter of intention to provide a ‘no objection’ statement and Initial Orders from the High Court have been granted to conduct the Scheme Meeting.
The Scheme Meeting and the Annual Meeting of Shareholders will both be held at 2.00pm on Wednesday, 25 September 2024 (New Zealand time) at JW Marriott (Ballroom 1 & 2), 22-26 Albert Street, Auckland, and simultaneously online via Computershare's virtual meeting platform (https://meetnow.global/nz).
For the Scheme to be implemented, both of the following voting thresholds must be met:
• 75% or more of the votes cast in each interest class must be voted in favour of the Scheme Resolution; and
• more than 50% of the total number of Arvida shares on issue and entitled to vote must be voted in favour of the Scheme Resolution.
– ENDS –
Latest NZX releases
-
30 Aug 2024
Please see attached a Substantial Product Holder notice for UBS Group AG and its related bodies corporate in Arvida Grou...
-
29 Aug 2024
Key points: • Scheme Consideration of NZ$1.70 per share is within the Independent Adviser’s assessed valuation range at...
-
29 Aug 2024
Arvida Group Limited (Arvida) advises that initial orders have been received from the High Court for the scheme of arran...
-
27 Aug 2024
Annual Meeting The Annual Meeting of Shareholders of Arvida Group Limited (Arvida) will be held on Wednesday, 25 Septem...